000 02209cam a2200313 4500500
005 20250629030510.0
041 _afre
042 _adc
100 1 0 _aLalanne, Laurence
_eauthor
700 1 0 _a Lutz, Pierre-Éric
_eauthor
700 1 0 _a Caparros-Roissard, Alba
_eauthor
700 1 0 _a Waeckerle, Gauthier
_eauthor
700 1 0 _a Scherer, Camille
_eauthor
700 1 0 _a Lebreton, Mireille
_eauthor
700 1 0 _a Audran, Martin
_eauthor
700 1 0 _a Merah, Ismahane
_eauthor
700 1 0 _a Chappuy, Mathieu
_eauthor
700 1 0 _a Avril, Elisabeth
_eauthor
700 1 0 _a Detrez, Victor
_eauthor
700 1 0 _a Lazic, Jamel
_eauthor
700 1 0 _a Rolland, Benjamin
_eauthor
700 1 0 _a Jauffret-Roustide, Marie
_eauthor
245 0 0 _aExploring the biopsychosocial determinants of opioid use disorder severity: The BEBOP cohort
260 _c2025.
500 _a12
520 _aOver the last decades, it has been demonstrated that opioid use disorder (OUD) results from the combined effects of many factors, including those of a psychosocial and neurobiological nature. This plurality is embodied in a comprehensive theoretical framework: the biopsychosocial model of addiction. While the impact of each factor on the severity of OUD has been well identified, their combined effect is unknown. In this context, the BEBOP project is based on a collaboration between psychiatrists, sociologists, and neuroepigeneticists. The primary objective is to characterize the severity of the psychosocial factors of OUD in a cohort of patients, with the aim of covering the full spectrum of the disorder’s severity. The secondary objectives are, first, to establish a correlation between the level of psychosocial severity and epigenetic biomarkers in order to understand the determinants of OUD severity, and, second, to determine whether epigenetic biomarkers can be predictive of OUD outcomes. Ultimately, the results of the BEBOP project will make it possible to tailor OUD treatment based on its severity.
786 0 _nPsychotropes | 31 | 2-3 | 2025-06-24 | p. 97-111 | 1245-2092
856 4 1 _uhttps://shs.cairn.info/journal-psychotropes-2025-2-3-page-97?lang=en&redirect-ssocas=7080
999 _c1373598
_d1373598